← SynDRA
SILDENAFIL
SynDRA canonical compound SYN0007825 — structure-anchored drug synonym record
| Clinical phase | Launched |
|---|
| Approval status | Approved · Rx/OTC |
|---|
| Primary target(s) | PDE5A |
|---|
| Mechanism of action | Phosphodiesterase inhibitor |
|---|
| Indication | erectile dysfunction |
|---|
| Disease area | urology |
|---|
All known targets
- PDE5A
- SLCO1B3
- ABCC5
- PDE6G
- PDE6H
- PDE6C
- Pde1b
- PDE7A
- PDE8A
- PDE9A
- Pde1a
- Pde1c
Mechanisms of action (all sources)
- Phosphodiesterase inhibitor
- PDE5A INHIBITOR
- Phosphodiesterase 5A inhibitor
- ABCC5 INHIBITOR
- SLCO1B3 INHIBITOR
- SLCO2B1 INHIBITOR
- PDE6C INHIBITOR
- SERPING1 MODULATOR
Drug classes
- Phosphodiesterase 5 Inhibitors
- Cardiovascular Agents
- Enzyme Inhibitors
- Phosphodiesterase Inhibitors
- Urological Agents
- Vasodilator Agents
- Phosphodiesterase 5 Inhibitor
ATC classes
Cross-references
Synonyms
- mysildecard
- sildenafil citrate
- revatio
- Sildenafilo
- HIP-0908
- HIP0908
- UK-92480
- Rhucin
- VIAGRA
- Sildenafil [INN:BAN]
- UNII-3M7OB98Y7H
- UK-92,480-10
- C22H30N6O4S
- HSDB 7305
- CHEMBL192
- UK 92480-10
- CHEBI:9139
- 3M7OB98Y7H
- 1-((3-(4,7-Dihydro-1-methyl-7-oxo-3-propyl-1H-pyrazolo(4,3-d)pyrimidin-5-yl)-4-ethoxyphenyl)sulfonyl)-4-methylpiperazine
- BNRNXUUZRGQAQC-UHFFFAOYSA-N
- 5-(2-Ethoxy-5-((4-methylpiperazin-1-yl)sulfonyl)phenyl)-1-methyl-3-propyl-1H-pyrazolo[4,3-d]pyrimidin-7(6H)-one
- Sildenafil ratiopharm
- Aphrodil
- Patrex
- Sildenafil actavis
- Sildenafil teva
- Vizarsin
- sildenafilum
- Nipatra
- RefChem:6218
- DTXCID003579
- G04BE03
- Sildenafil (INN)
- UK 92480
- SILDENAFIL [INN]
- Aphrodil (TN)
- SMR000752512
- SR-05000001934
Reported adverse events
- Dyspepsia
- Flushing
- Headache
- Hypotension
- Myalgia
- Nausea
- Nasal congestion
- Epistaxis
- Dizziness
- Rash
- Back pain
- Rhinitis
Look up SILDENAFIL in the interactive SynDRA portal →